These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 3119749

  • 21. Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.
    Martinez J, Palascak JE, Kwasniak D.
    J Clin Invest; 1978 Feb; 61(2):535-8. PubMed ID: 621288
    [Abstract] [Full Text] [Related]

  • 22. ["Lupus anticoagulant" in immune hyperthyroidism].
    Schuler G, Alexopoulos A, Hasler K, Kerp L.
    Dtsch Med Wochenschr; 1990 Oct 05; 115(40):1511-4. PubMed ID: 2120025
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lupus anticoagulant syndrome: case report.
    Mwanda OW.
    East Afr Med J; 1998 Oct 05; 75(10):619-20. PubMed ID: 10065201
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lupus anticoagulant after measles.
    Muntean W, Petek W.
    Eur J Pediatr; 1980 Aug 05; 134(2):135-8. PubMed ID: 6777164
    [Abstract] [Full Text] [Related]

  • 27. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT, Triplett DA, Musgrave K, Orr C.
    Arch Pathol Lab Med; 1987 Feb 05; 111(2):120-4. PubMed ID: 3101649
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
    Llobet D, Borrell M, Vila L, Vallvé C, Felices R, Fontcuberta J.
    Haematologica; 2007 Feb 05; 92(2):e17-9. PubMed ID: 17405747
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, Caen J.
    Thromb Haemost; 1988 Aug 30; 60(1):54-8. PubMed ID: 2847352
    [Abstract] [Full Text] [Related]

  • 32. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA, Cuddigan B, VanRoss M, Kakkar VV.
    Br J Haematol; 1980 Mar 30; 44(3):483-94. PubMed ID: 6769460
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ, Dubick MA, Wade CE, Holcomb JB.
    Crit Care Med; 2007 Jun 30; 35(6):1568-74. PubMed ID: 17452929
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M, Leupin L, Biasiutti FD, Lämmle B.
    Schweiz Med Wochenschr; 1991 Jul 20; 121(29):1068-71. PubMed ID: 1891701
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reducing the use of coagulation test panels.
    Amukele TK, Baird GS, Chandler WL.
    Blood Coagul Fibrinolysis; 2011 Dec 20; 22(8):688-95. PubMed ID: 21934488
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.